MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 9, 2005; DOI: 10.1124/mol.105.015271


0026-895X/05/6806-1803-1809$20.00
Mol Pharmacol 68:1803-1809, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.015271v1
68/6/1803    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, K.-O.
Right arrow Articles by Park, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, K.-O.
Right arrow Articles by Park, H.

Inhibition of the Catalytic Activity of Hypoxia-Inducible Factor-1{alpha}-Prolyl-Hydroxylase 2 by a MYND-Type Zinc Finger

Kyung-Ok Choi, Taekyong Lee, Naery Lee1, Ji-Hyun Kim, Eun Gyeong Yang, Jung Min Yoon, Jin Hwan Kim, Tae Gyu Lee, and Hyunsung Park

Department of Life Science, University of Seoul, Seoul, Korea (K.-O.C., T.L., N.L., H.P.); Life Science Division, Korea Institute of Science and Technology, Seoul, Korea (J.-H.K., E.G.Y.); and the Division of Drug Discovery, CrystalGenomics, Inc., Daejeon City, Korea (J.M.Y., J.H.K., T.G.L.)

Hypoxia-induced gene expression is initiated when the hypoxia-inducible factor-1 (HIF-1) {alpha} subunit is stabilized in response to a lack of oxygen. An HIF-1{alpha}-specific prolyl-hydroxylase (PHD) catalyzes hydroxylation of the proline-564 and/or -402 residues of HIF-1{alpha} by an oxygen molecule. The hydroxyproline then interacts with the ubiquitin E3 ligase von Hippel Lindau protein and is degraded by an ubiquitin-dependent proteasome. PHD2 is the most active of three PHD isoforms in hydroxylating HIF-1{alpha}. Structural analysis showed that the N-terminal region of PHD2 contains a Myeloid translocation protein 8, Nervy, and DEAF1 (MYND)-type zinc finger domain, whereas the catalytic domain is located in its C-terminal region. We found that deletion of the MYND domain increased the activity of both recombinant PHD2 protein and in vitro-translated PHD2. The zinc chelator N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine augmented the activity of wild-type PHD2-F but not that of PHD2 lacking the MYND domain, confirming that the zinc finger domain is inhibitory. Overexpression of PHD2 lacking the MYND domain caused a greater reduction in the stability and function of HIF-1{alpha} than did overexpression of wild-type PHD2, indicating that the MYND domain also inhibits the catalytic activity of PHD2 in vivo.


Received May 26, 2005; accepted September 9, 2005

Address correspondence to: Dr. Hyunsung Park, Department of Life Science, University of Seoul, 90 Cheonnong-dong, Tongdaemun-gu, Seoul 130-743, Korea. E-mail: hspark{at}uos.ac.kr.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
Y. Benita, H. Kikuchi, A. D. Smith, M. Q. Zhang, D. C. Chung, and R. J. Xavier
An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia
Nucleic Acids Res., June 2, 2009; (2009) gkp425v1.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y.-K. Park, D.-R. Ahn, M. Oh, T. Lee, E. G. Yang, M. Son, and H. Park
Nitric Oxide Donor, ({+/-})-S-Nitroso-N-acetylpenicillamine, Stabilizes Transactive Hypoxia-Inducible Factor-1{alpha} by Inhibiting von Hippel-Lindau Recruitment and Asparagine Hydroxylation
Mol. Pharmacol., July 1, 2008; 74(1): 236 - 245.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. Lee, J. D. Lynd, S. O'Reilly, M. Kiupel, J. J. McCormick, and J. J. LaPres
The Biphasic Role of the Hypoxia-Inducible Factor Prolyl-4-Hydroxylase, PHD2, in Modulating Tumor-Forming Potential
Mol. Cancer Res., May 1, 2008; 6(5): 829 - 842.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Ju, X. Wang, H. Xu, and Y. Xie
Genome-Wide Analysis Identifies MYND-Domain Protein Mub1 as an Essential Factor for Rpn4 Ubiquitylation
Mol. Cell. Biol., February 15, 2008; 28(4): 1404 - 1412.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Flashman, E. A. L. Bagg, R. Chowdhury, J. Mecinovic, C. Loenarz, M. A. McDonough, K. S. Hewitson, and C. J. Schofield
Kinetic Rationale for Selectivity toward N- and C-terminal Oxygen-dependent Degradation Domain Substrates Mediated by a Loop Region of Hypoxia-Inducible Factor Prolyl Hydroxylases
J. Biol. Chem., February 15, 2008; 283(7): 3808 - 3815.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. K. Koski, R. Hieta, C. Bollner, K. I. Kivirikko, J. Myllyharju, and R. K. Wierenga
The Active Site of an Algal Prolyl 4-Hydroxylase Has a Large Structural Plasticity
J. Biol. Chem., December 21, 2007; 282(51): 37112 - 37123.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
K. Keskiaho, R. Hieta, R. Sormunen, and J. Myllyharju
Chlamydomonas reinhardtii Has Multiple Prolyl 4-Hydroxylases, One of Which Is Essential for Proper Cell Wall Assembly
PLANT CELL, January 1, 2007; 19(1): 256 - 269.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Choi, K.-O. Choi, Y.-K. Park, H. Cho, E. G. Yang, and H. Park
Clioquinol, a Cu(II)/Zn(II) Chelator, Inhibits Both Ubiquitination and Asparagine Hydroxylation of Hypoxia-inducible Factor-1{alpha}, Leading to Expression of Vascular Endothelial Growth Factor and Erythropoietin in Normoxic Cells
J. Biol. Chem., November 10, 2006; 281(45): 34056 - 34063.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics